Modernatx, Inc.

This study tested a single vaccine shot designed to protect against both COVID-19 and seasonal influenza. It involved 932 adults aged 50 to 65 to check the vaccine's safety and how well it triggers an immune response. Researchers compared different versions of the vaccine to see …

This study tested a new mRNA vaccine designed to protect against both seasonal flu and COVID-19 in a single shot. It involved about 1,758 healthy adults and aimed to find the safest and most effective dose. The main goals were to check for side effects and see how well the vaccin…

This study followed adults who had previously received an experimental CMV vaccine to see how long their immune protection lasted. Some participants later received a booster dose to see if it safely renewed their protection. The goal was to understand the vaccine's long-term safe…

This study tested a new Moderna vaccine designed to protect against both COVID-19 and seasonal influenza with a single injection. It involved over 2,400 healthy adults aged 50 and older in Asia. The main goal was to see how well the body's immune system responded to the combined …

This large, completed study tested Moderna's experimental mRNA flu vaccine, called mRNA-1010, against a standard, already-approved flu shot. It involved over 40,000 adults aged 50 and older. The main goals were to see if the new vaccine is safe and if it works better at preventin…

This study tested the Moderna COVID-19 vaccine in over 4,300 healthy adolescents aged 12 to 17. The main goals were to check the vaccine's safety, side effects, and how well it worked to prevent COVID-19. Researchers compared the teens' immune responses to those seen in young adu…

This study tested updated Moderna COVID-19 vaccines designed to protect against newer virus variants in children from 6 months to under 6 years old. Researchers enrolled about 1,800 children to check how safe the vaccines are and how well they trigger an immune response. The stud…

This study tested a new flu vaccine made with mRNA technology, similar to Moderna's COVID-19 vaccine. It involved 172 healthy adults and compared the new vaccine's safety and ability to trigger an immune response against standard flu shots. The main goal was to see if the mRNA va…

This study tested the safety and immune response of an experimental mRNA vaccine (mRNA-1893) designed to prevent Zika virus infection. It involved 808 healthy adults, some with and some without prior exposure to similar viruses like dengue. Researchers compared two different vacc…

This study tested a new vaccine, mRNA-1083, designed to protect against both seasonal flu and COVID-19 with a single shot. It involved 1,320 healthy adults aged 18-65 to see how well their immune systems responded and to check for side effects. The goal was to see if this combina…

This study tested two new mRNA vaccine candidates designed to prevent Lyme disease. It involved 807 healthy adults to see if the vaccines were safe and if they triggered a good immune response against the bacteria that causes Lyme. The study compared different doses of the vaccin…

This study tested a new mRNA vaccine (mRNA-1345) designed to protect against Respiratory Syncytial Virus (RSV) in adults aged 50 and older. Researchers wanted to see if it was safe and effective when given alone, or at the same time as a seasonal flu shot or an updated COVID-19 v…

This study aimed to check if Moderna's updated COVID-19 booster vaccine affects levels of a protein in the blood that can indicate heart stress. Researchers enrolled 1,000 healthy participants aged 12 to 30 and measured this protein before and after vaccination, comparing results…